$4.28
4.21%
Downside
Day's Volatility :6.39%
Upside
2.28%
24.07%
Downside
52 Weeks Volatility :92.43%
Upside
90.03%
Period | Seastar Medical Holding Corp | Index (Russel 2000) |
---|---|---|
3 Months | -62.82% | 0.0% |
6 Months | -74.03% | 0.0% |
1 Year | -67.99% | 0.0% |
3 Years | -98.42% | -20.1% |
Market Capitalization | 18.0M |
Book Value | - $2.14 |
Earnings Per Share (EPS) | -18.55 |
Wall Street Target Price | 18.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -308.09% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -18.55 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -7.99 |
EPS Estimate Next Year | -2.57 |
EPS Estimate Current Quarter | -1.41 |
EPS Estimate Next Quarter | -1.25 |
What analysts predicted
Upside of 320.56%
Sell
Neutral
Buy
Seastar Medical Holding Corp is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Seastar Medical Holding Corp | -11.36% | -74.03% | -67.99% | -98.42% | -98.42% |
Regeneron Pharmaceuticals, Inc. | -10.33% | 8.11% | 21.28% | 85.63% | 257.49% |
Novo Nordisk A/s | -12.25% | -9.71% | 24.92% | 138.38% | 343.21% |
Alnylam Pharmaceuticals, Inc. | 9.22% | 72.73% | 52.35% | 34.04% | 250.13% |
Vertex Pharmaceuticals Incorporated | -3.09% | 12.2% | 25.77% | 150.7% | 163.62% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Seastar Medical Holding Corp | NA | NA | NA | -7.99 | 0.0 | -3.08 | NA | -2.14 |
Regeneron Pharmaceuticals, Inc. | 27.55 | 27.55 | 1.42 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 38.7 | 38.7 | 1.75 | 3.41 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.49 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.55 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Seastar Medical Holding Corp | Buy | $18.0M | -98.42% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $114.7B | 257.49% | 27.55 | 32.04% |
Novo Nordisk A/s | Buy | $518.0B | 343.21% | 38.7 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $34.9B | 250.13% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $119.3B | 163.62% | 32.84 | -4.74% |
Insights on Seastar Medical Holding Corp
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 52.3% return, outperforming this stock by 120.3%
Bank of America Corp
Geode Capital Management, LLC
UBS Group AG
Vanguard Group Inc
Morgan Stanley - Brokerage Accounts
BlackRock Inc
Organization | Seastar Medical Holding Corp |
Employees | 12 |
CEO | Mr. Eric Schlorff |
Industry | Miscellaneous |
Graniteshares 2x Long Baba Daily Etf
$4.28
-0.23%
Mingteng International Corp Inc
$4.28
-0.23%
Direct Digital Holdings Inc
$4.28
-0.23%
Dt Cloud Star Acquisition Corporation Right
$4.28
-0.23%
Precipio Inc
$4.28
-0.23%
Venus Concept Inc
$4.28
-0.23%
Fidelity Msci Materials Etf
$4.28
-0.23%
Inspire International Etf
$4.28
-0.23%
First Trust Dorsey Wright Momentum & Value Etf
$4.28
-0.23%